Intuitive Surgical stock hits 52-week high at $562

Published 15/01/2025, 15:36
Intuitive Surgical stock hits 52-week high at $562

Intuitive Surgical Inc . (NASDAQ:ISRG) shares soared to a 52-week high, reaching a price level of $562, marking a significant milestone for the company known for its da Vinci (EPA:SGEF) surgical systems. According to InvestingPro data, the company commands a substantial market capitalization of $195.9 billion, with current valuation metrics suggesting the stock is trading above its Fair Value. This peak reflects a robust 48.73% increase in stock value over the past year, underscoring investor confidence and the company's strong performance in the medical technology sector. The impressive one-year change highlights Intuitive Surgical's continued growth, supported by a 14.83% revenue growth and an excellent profit score of 4.21 out of 5 on InvestingPro. With earnings scheduled for January 23rd and twelve additional ProTips available, investors seeking deeper insights can access the comprehensive Pro Research Report, which provides detailed analysis of this leading surgical robotics innovator.

In other recent news, Intuitive reported robust Q4 and full-year 2024 results, surpassing consensus estimates. The company achieved a Q4 revenue of approximately $2.41 billion, marking a 25% increase from the same quarter last year. Full-year revenue was around $8.35 billion, a 17% rise from 2023. This growth is attributed to the increase in da Vinci and Ion procedure volume and customer buying patterns.

Intuitive placed 493 da Vinci surgical systems in Q4 2024, a 19% increase from 2023, showing sustained demand for its products. Da Vinci procedures grew by 17% in 2024, with the company expecting this growth to continue at a rate of 13% to 16% in 2025. These developments come on the heels of executive promotions at Intuitive, with Jamie E. Samath and Henry L. Charlton both receiving promotions and pay raises.

Analysts from Mizuho (NYSE:MFG) Securities and Truist Securities have responded positively to these developments, with Truist Securities increasing its price target for Intuitive shares. Piper Sandler analysts also expressed optimism for several healthcare companies, including Intuitive, ahead of a major investor conference. These are the recent developments in the healthcare sector, providing investors with key insights and expectations for the future.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.